Classification of Aβ State From Brain Amyloid PET Images Using Machine Learning Algorithm
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose: Analyzing brain amyloid positron emission tomography (PET) images to access the occurrence of β-amyloid (Aβ) deposition in Alzheimer’s patients requires much time and effort from physicians, while the variation of each interpreter may differ. For these reasons, a machine learning model was developed using a convolutional neural network (CNN) as an objective decision to classify the Aβ positive and Aβ negative status from brain amyloid PET images. Methods: A total of 7,344 PET images of 144 subjects were used in this study. The 18F-florbetaben PET was administered to all participants, and the criteria for differentiating Aβ positive and Aβ negative state was based on brain amyloid plaque load score (BAPL) that depended on the visual assessment of PET images by the physicians. We applied the CNN algorithm trained in batches of 51 PET images per subject directory from 2 classes: Aβ positive and Aβ negative states, based on the BAPL scores. Results: The binary classification of the model average performance matrices was evaluated after 40 epochs of three trials based on test datasets. The model accuracy for classifying Aβ positivity and Aβ negativity was (95.00±0.02) in the test dataset. The sensitivity and specificity were (96.00±0.02) and (94.00±0.02), respectively, with an area under the curve of (87.00±0.03). Conclusions: Based on this study, the designed CNN model has the potential to be used clinically to screen amyloid PET images.
Abstract
Background and Purpose: Analyzing brain amyloid positron emission tomography (PET) images to access the occurrence of β-amyloid (Aβ) deposition in Alzheimer’s patients requires much time and effort from physicians, while the variation of each interpreter may differ. For these reasons, a machine learning model was developed using a convolutional neural network (CNN) as an objective decision to classify the Aβ positive and Aβ negative status from brain amyloid PET images. Methods: A total of 7,344 PET images of 144 subjects were used in this study. The 18F-florbetaben PET was administered to all participants, and the criteria for differentiating Aβ positive and Aβ negative state was based on brain amyloid plaque load score (BAPL) that depended on the visual assessment of PET images by the physicians. We applied the CNN algorithm trained in batches of 51 PET images per subject directory from 2 classes: Aβ positive and Aβ negative states, based on the BAPL scores. Results: The binary classification of the model average performance matrices was evaluated after 40 epochs of three trials based on test datasets. The model accuracy for classifying Aβ positivity and Aβ negativity was (95.00±0.02) in the test dataset. The sensitivity and specificity were (96.00±0.02) and (94.00±0.02), respectively, with an area under the curve of (87.00±0.03). Conclusions: Based on this study, the designed CNN model has the potential to be used clinically to screen amyloid PET images.
참고문헌 (16)
- Porsteinsson AP, "Diagnosis of early Alzheimer’s disease : clinical practice in 2021", J Prev Alzheimers Dis, 8, pp.371~386 (2021)
- Shi M, "Biomarker discovery in neurodegenerative diseases : a proteomic approach", Neurobiol Dis, 35, pp.157~164 (2009)
- Mantzavinos V, "Biomarkers for Alzheimer’s disease diagnosis", Curr Alzheimer Res, 14, pp.1149~1154 (2017)
- Jinny Claire Lee, "Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers", Experimental and Molecular Medicine, 51, pp.1~10 (2019), 생화학분자생물학회[DOI]
- 조국, "Classification of 18F-Florbetaben Amyloid Brain PET Image using PCA-SVM", 대한의생명과학회지, 25(1), pp.99~106 (2019), 대한의생명과학회
- Florbetaben (FBB) PET Imaging, Pathology, and Cognition between Normal and Alzheimer Transgenic Mice, "대한의생명과학회지", 2019, 7~14, pp.대한의생명과학회
- Barthel H, "Cerebral amyloid-β PET with florbetaben(18F)in patients with Alzheimer’s disease and healthy controls : a multicentre phase 2 diagnostic study", Lancet Neurol, 10, pp.424~435 (2011)
- Tsubaki Y, "Development and evaluation of an automated quantification tool for amyloid PET images", EJNMMI Phys, 7, pp.59~ (2020)
- Cho SH, "Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments", Sci Rep, 10, pp.19576~ (2020)
- 강현, "VGG-based BAPL Score Classification of 18F-Florbetaben Amyloid Brain PET", 대한의생명과학회지, 24(4), pp.418~425 (2018), 대한의생명과학회[DOI]
- Florbetaben PET supported by deep learning-based estimation of amyloid burden, "Eur J Nucl Med Mol Imaging", 2021, 1116~1123
- Lin W, "Convolutional neural networks-based MRI image analysis for the Alzheimer’s disease prediction from mild cognitive impairment", Front Neurosci, 12, pp.777~ (2018)
- Sato R, "Innovation in Medicine and Healthcare Systems, and Multimedia", pp.169~177 (2019), Springer
- Ting KM, "Encyclopedia of Machine Learning", pp.209~ (2011), Springer
- Simfukwe Chanda, "Comparison of RCF Scoring System to Clinical Decision for the Rey Complex Figure Using Machine-Learning Algorithm", Dementia and Neurocognitive Disorders(대한치매학회지), 20(4), pp.70~79 (2021), 대한치매학회[DOI]
- Sato R, "Accurate BAPL score classification of brain PET images based on convolutional neural networks with a joint discriminative loss function", Appl Sci(Basel), 10, pp.965~ (2020)